One of the biggest game changers in the Indian pharma space, Murli Krishna Pharma Pvt. Ltd. owns an advanced manufacturing unit in the heart of Ranjangaon, Maharashtra. The unit is a well-equipped, state-of-the-art facility that provides quality drug delivery solutions. The organisation has not only been approved by the EU and JFDA but also by the key end-users based out of the EU. With its production area rated at class 100 K, the plant is equipped with the best machinery to ensure the highest quality standards in the DDSs. The company adopts strict measures to ensure no lapses are experienced on the production front. Various departments work in tandem to monitor different stages of production and ensure every protocol is complied with. The company enjoys reputation for its ability to provide personalised solutions to its clientele spread across the world. Its ‘after-deliverance of technology’ service is also making a ripple in the market.